Seeing Is Believing
with an average price target of $619.55. This is a potential upside of $613.68 (10454.51%) from yesterday's end of day stock price of $5.87.
NovaBay Pharmaceuticals's activity chart (see below) currently has 4 price targets and 4 ratings on display.
Analysts average stock forecasts to be materialized ratio is 62.5% with an average time for these price targets to be met of 140.25 days.
Most recent stock forecast was given by EDWARD WOO from ASCENDIANT on 11-Nov-2024. First documented stock forecast 05-Jun-2017.
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 11-Nov-2024
$0.85
$-13.92 (-94.25%)
1 years 2 months 11 days ago
(11-Nov-2024)
1/1 (100%)
$0.38 (80.85%)
289
Buy
$3.8
$3.35 (744.44%)
2 years 5 months 11 days ago
(11-Aug-2023)
1/2 (50%)
$7.02 (252.09%)
183
Buy
Since 13-Mar-2019
$1531.25
$1516.48 (10267.30%)
6 years 10 months 9 days ago
(13-Mar-2019)
1/1 (100%)
$421.9 (38.03%)
89
Hold
Since 26-Mar-2018
$4900
$4885.23 (33075.36%)
$6737.5
7 years 9 months 27 days ago
(26-Mar-2018)
0/2 (0%)
$2025.4 (70.46%)
What is NBY (NovaBay Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on NBY (NovaBay Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on NBY (NovaBay Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on NBY (NovaBay Pharmaceuticals)?
Which analyst is the currently most bullish on NBY (NovaBay Pharmaceuticals)?
Which analyst is the currently most reserved on NBY (NovaBay Pharmaceuticals)?